QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
28.42
+1.11 (4.06%)
Oct 16, 2025, 4:00 PM EDT - Market closed
QuidelOrtho Revenue
QuidelOrtho had revenue of $613.90M in the quarter ending June 29, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to $2.74B, down -3.28% year-over-year. In the year 2024, QuidelOrtho had annual revenue of $2.78B, down -7.17%.
Revenue (ttm)
$2.74B
Revenue Growth
-3.28%
P/S Ratio
0.70
Revenue / Employee
$415,394
Employees
6,600
Market Cap
1.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
Jan 3, 2021 | 1.66B | 1.13B | 210.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
QDEL News
- 6 hours ago - QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 - PRNewsWire
- 21 days ago - Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters - PRNewsWire
- 24 days ago - QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use - PRNewsWire
- 7 weeks ago - QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference - PRNewsWire
- 2 months ago - QuidelOrtho Completes Debt Refinancing - PRNewsWire
- 2 months ago - Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities - PRNewsWire
- 2 months ago - QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development - PRNewsWire
- 2 months ago - QuidelOrtho Launches Certified Analyzer Program - PRNewsWire